Related Experiment Video
Updated: Jun 12, 2026
07:41
Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
Published on: June 8, 2022
5.0K
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology.
Szu-Chi Liao1,2,3,4, Kohei Kano1,4, Sadhna Phanse5
1Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Science Advances
|November 14, 2025
Summary
Mitochondrial protein CHCHD2 accumulation drives Parkinson's disease by impairing cellular respiration and increasing oxidative stress, leading to alpha-synuclein aggregation and neurodegeneration.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Genetics
Background:
- Mitochondrial dysfunction is central to Parkinson's disease (PD) pathogenesis.
- Mechanisms linking mitochondrial issues to PD, particularly idiopathic forms, are not fully understood.
Purpose of the Study:
- To investigate the role of the mitochondrial protein CHCHD2 in PD pathogenesis.
- To analyze a knock-in mouse model with a CHCHD2 T61I mutation causing PD-like symptoms.
Main Methods:
- Generated and analyzed a CHCHD2 T61I knock-in mouse model.
- Performed comprehensive phenotypic and biochemical analyses of dopaminergic neurons and brain tissue.
- Examined mitochondrial structure, protein interactions, metabolic shifts, ROS production, and alpha-synuclein aggregation.
Main Results:
- CHCHD2 T61I mutation caused mitochondrial disruption and aggregation in dopaminergic neurons.
- Observed metabolic shift to glycolysis, increased mitochondrial ROS, and progressive alpha-synuclein accumulation.
- CHCHD2 accumulation correlated with alpha-synuclein in idiopathic PD and was found in Lewy aggregates.
Conclusions:
- CHCHD2 accumulation initiates a pathogenic cascade in PD.
- Impaired mitochondrial respiration and increased ROS by CHCHD2 drive alpha-synuclein aggregation and neurodegeneration.
- This provides a mechanistic link between mitochondrial dysfunction and PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...